Median Technologies

ALMDT

Company Profile

  • Business description

    Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.

  • Contact

    1800 Route Des Cretes
    Les Deux Arcs B
    Valbonne06560
    FRA

    T: +33 493333777

    https://www.mediantechnologies.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    211

Stocks News & Analysis

stocks

Palantir earnings: AI leadership intact; valuation still causes heartburn

Our view of Palantir Technologies.
stocks

Market underestimating cheap ASX share

Investors missing the big opportunity in batteries.
stocks

As Nvidia crosses $5 trillion, 5 charts on the unstoppable tech rally

Demand for AI has catapulted tech stocks into the stratosphere.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,071.2019.30-0.21%
CAC 408,067.970.440.01%
DAX 4023,889.2459.87-0.25%
Dow JONES (US)47,085.24251.44-0.53%
FTSE 1009,728.8113.850.14%
HKSE25,935.4116.99-0.07%
NASDAQ23,348.64486.09-2.04%
Nikkei 22550,212.271,284.93-2.50%
NZX 50 Index13,620.9815.020.11%
S&P 5006,771.5580.42-1.17%
S&P/ASX 2008,802.007.80-0.09%
SSE Composite Index3,969.259.060.23%

Market Movers